177 related articles for article (PubMed ID: 11106188)
21. Collagen types I and III in giant papillae of vernal keratoconjunctivitis.
Leonardi A; Abatangelo G; Cortivo R; Secchi AG
Br J Ophthalmol; 1995 May; 79(5):482-5. PubMed ID: 7612563
[TBL] [Abstract][Full Text] [Related]
22. A large prospective observational study of novel cyclosporine 0.1% aqueous ophthalmic solution in the treatment of severe allergic conjunctivitis.
Ebihara N; Ohashi Y; Uchio E; Okamoto S; Kumagai N; Shoji J; Takamura E; Nakagawa Y; Nanba K; Fukushima A; Fujishima H
J Ocul Pharmacol Ther; 2009 Aug; 25(4):365-72. PubMed ID: 19441889
[TBL] [Abstract][Full Text] [Related]
23. Mechanisms of giant papillary formation in vernal keratoconjunctivitis.
Kato N; Fukagawa K; Dogru M; Fujishima H; Tsubota K
Cornea; 2006 Dec; 25(10 Suppl 1):S47-52. PubMed ID: 17001193
[TBL] [Abstract][Full Text] [Related]
24. Conjunctival expression of thymosin-beta4 in vernal keratoconjunctivitis.
Micera A; Bonini S; Lambiase A; Lapucci G; Bonini S; Rasi G
Mol Vis; 2006 Dec; 12():1594-600. PubMed ID: 17200658
[TBL] [Abstract][Full Text] [Related]
25. Quantitative evaluation of the early changes in ocular surface inflammation following MMC-aided papillary resection in severe allergic patients with corneal complications.
Tanaka M; Dogru M; Takano Y; Miyake-Kashima M; Asano-Kato N; Fukagawa K; Tsubota K; Fujishima H
Cornea; 2006 Apr; 25(3):281-5. PubMed ID: 16633027
[TBL] [Abstract][Full Text] [Related]
26. Vernal keratoconjunctivitis revisited: a case series of 195 patients with long-term followup.
Bonini S; Bonini S; Lambiase A; Marchi S; Pasqualetti P; Zuccaro O; Rama P; Magrini L; Juhas T; Bucci MG
Ophthalmology; 2000 Jun; 107(6):1157-63. PubMed ID: 10857837
[TBL] [Abstract][Full Text] [Related]
27. Transforming growth factor-β/Smad - signalling pathway and conjunctival remodelling in vernal keratoconjunctivitis.
Leonardi A; Di Stefano A; Motterle L; Zavan B; Abatangelo G; Brun P
Clin Exp Allergy; 2011 Jan; 41(1):52-60. PubMed ID: 20977504
[TBL] [Abstract][Full Text] [Related]
28. Surgical debridement of corneal shield ulcers in pediatric patients: two case reports and a review of the literature.
Stock RA; Lazzari SLT; Martins IP; Bonamigo EL
J Med Case Rep; 2020 Jun; 14(1):70. PubMed ID: 32546209
[TBL] [Abstract][Full Text] [Related]
29. Vernal shield ulcers treated with frequently installed topical cyclosporine 0.05% eyedrops.
Westland T; Patryn EK; Nieuwendaal CP; van der Meulen IJE; Mourits MP; Lapid-Gortzak R
Int Ophthalmol; 2018 Feb; 38(1):363-368. PubMed ID: 28120172
[TBL] [Abstract][Full Text] [Related]
30. Usefulness of a new therapy using rebamipide eyedrops in patients with VKC/AKC refractory to conventional anti-allergic treatments.
Ueta M; Sotozono C; Koga A; Yokoi N; Kinoshita S
Allergol Int; 2014 Mar; 63(1):75-81. PubMed ID: 24457813
[TBL] [Abstract][Full Text] [Related]
31. The differences of tear function and ocular surface findings in patients with atopic keratoconjunctivitis and vernal keratoconjunctivitis.
Hu Y; Matsumoto Y; Dogru M; Okada N; Igarashi A; Fukagawa K; Tsubota K; Fujishima H
Allergy; 2007 Aug; 62(8):917-25. PubMed ID: 17620070
[TBL] [Abstract][Full Text] [Related]
32. Growth factors and collagen distribution in vernal keratoconjunctivitis.
Leonardi A; Brun P; Tavolato M; Abatangelo G; Plebani M; Secchi AG
Invest Ophthalmol Vis Sci; 2000 Dec; 41(13):4175-81. PubMed ID: 11095612
[TBL] [Abstract][Full Text] [Related]
33. Surgical management and immunohistochemical study of corneal plaques in vernal keratoconjunctivitis.
Lin HY; Yeh PT; Shiao CS; Hu FR
J Formos Med Assoc; 2013 Sep; 112(9):569-73. PubMed ID: 24079715
[TBL] [Abstract][Full Text] [Related]
34. Use of cyclosporine A and tacrolimus in treatment of vernal keratoconjunctivitis.
Vichyanond P; Kosrirukvongs P
Curr Allergy Asthma Rep; 2013 Jun; 13(3):308-14. PubMed ID: 23625179
[TBL] [Abstract][Full Text] [Related]
35. Combined medical and surgical treatment of severe vernal keratoconjunctivitis.
Fujishima H; Fukagawa K; Satake Y; Saito I; Shimazaki J; Takano Y; Tsubota K
Jpn J Ophthalmol; 2000; 44(5):511-5. PubMed ID: 11033129
[TBL] [Abstract][Full Text] [Related]
36. Japanese guidelines for allergic conjunctival diseases 2020.
Miyazaki D; Takamura E; Uchio E; Ebihara N; Ohno S; Ohashi Y; Okamoto S; Satake Y; Shoji J; Namba K; Fukagawa K; Fukushima A; Fujishima H; ;
Allergol Int; 2020 Jul; 69(3):346-355. PubMed ID: 33211650
[TBL] [Abstract][Full Text] [Related]
37. A Case of Shield Ulcer Due to Vernal Keratoconjunctivitis.
Özkaya D; Usta G; Karaca U
Iran J Allergy Asthma Immunol; 2021 Aug; 20(4):505-508. PubMed ID: 34418905
[TBL] [Abstract][Full Text] [Related]
38. Fibroblasts as local immune modulators in ocular allergic disease.
Fukuda K; Kumagai N; Fujitsu Y; Nishida T
Allergol Int; 2006 Jun; 55(2):121-9. PubMed ID: 17075248
[TBL] [Abstract][Full Text] [Related]
39. Surgical debridement plus topical cyclosporine A in the treatment of vernal shield ulcers.
Caputo R; Pucci N; Mori F; De Libero C; Di Grande L; Bacci GM
Int J Immunopathol Pharmacol; 2012; 25(3):775-80. PubMed ID: 23058030
[TBL] [Abstract][Full Text] [Related]
40. Vernal Keratoconjunctivitis: an update focused on clinical grading system.
Zicari AM; Capata G; Nebbioso M; De Castro G; Midulla F; Leonardi L; Loffredo L; Spalice A; Perri L; Duse M
Ital J Pediatr; 2019 May; 45(1):64. PubMed ID: 31113464
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
